Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.400
0.00 (0.00%)
Mar 9, 2026, 2:45 PM EST
Elite Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 430 | 465 | 157 | 29 | 35 | 62 | Upgrade
|
| Market Cap Growth | -19.07% | 195.83% | 434.24% | -16.81% | -42.59% | 1.75% | Upgrade
|
| Enterprise Value | 415 | 468 | 159 | 27 | 31 | 61 | Upgrade
|
| Last Close Price | 0.40 | 0.43 | 0.15 | 0.03 | 0.03 | 0.06 | Upgrade
|
| PE Ratio | 11.20 | - | 7.81 | 8.26 | 3.97 | 12.10 | Upgrade
|
| PS Ratio | 3.07 | 5.53 | 2.77 | 0.86 | 1.10 | 2.42 | Upgrade
|
| PB Ratio | 5.35 | 8.68 | 2.73 | 1.01 | 1.40 | 3.81 | Upgrade
|
| P/TBV Ratio | 5.37 | 8.73 | 2.74 | 1.03 | 1.43 | 3.92 | Upgrade
|
| P/FCF Ratio | 24.93 | 79.70 | - | - | 5.88 | 21.50 | Upgrade
|
| P/OCF Ratio | 23.20 | 62.33 | - | 8.81 | 5.43 | 19.27 | Upgrade
|
| EV/Sales Ratio | 2.96 | 5.56 | 2.81 | 0.80 | 0.96 | 2.40 | Upgrade
|
| EV/EBITDA Ratio | 7.69 | 20.43 | 13.09 | 5.25 | 4.94 | 17.86 | Upgrade
|
| EV/EBIT Ratio | 8.02 | 22.05 | 14.75 | 6.92 | 6.11 | 28.90 | Upgrade
|
| EV/FCF Ratio | 24.05 | 80.19 | - | - | 5.15 | 21.24 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.20 | 0.20 | 0.13 | 0.11 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.46 | 0.95 | 0.73 | 0.43 | 0.66 | Upgrade
|
| Debt / FCF Ratio | 0.35 | 1.87 | - | - | 0.46 | 0.83 | Upgrade
|
| Net Debt / Equity Ratio | -0.19 | -0.01 | 0.08 | -0.14 | -0.23 | -0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.28 | -0.02 | 0.38 | -0.75 | -0.92 | -0.24 | Upgrade
|
| Net Debt / FCF Ratio | -0.87 | -0.07 | -1.14 | 1.65 | -0.96 | -0.28 | Upgrade
|
| Asset Turnover | 1.29 | 0.93 | 0.91 | 0.90 | 1.05 | 0.99 | Upgrade
|
| Inventory Turnover | 3.03 | 3.01 | 2.69 | 2.16 | 2.97 | 2.95 | Upgrade
|
| Quick Ratio | 5.28 | 3.42 | 2.04 | 1.40 | 1.73 | 1.15 | Upgrade
|
| Current Ratio | 7.34 | 4.88 | 3.07 | 2.75 | 2.82 | 2.10 | Upgrade
|
| Return on Equity (ROE) | 74.36% | -7.77% | 46.47% | 13.15% | 43.01% | 37.96% | Upgrade
|
| Return on Assets (ROA) | 29.75% | 14.72% | 10.83% | 6.52% | 10.33% | 5.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 76.25% | 36.77% | 24.74% | 15.95% | 29.14% | 14.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 45.60% | 25.10% | 15.30% | 12.00% | 17.80% | 10.30% | Upgrade
|
| Earnings Yield | 10.10% | -0.93% | 12.80% | 12.11% | 25.18% | 8.27% | Upgrade
|
| FCF Yield | 4.01% | 1.26% | -2.57% | -8.15% | 17.00% | 4.65% | Upgrade
|
| Buyback Yield / Dilution | -4.95% | -4.40% | -1.02% | -0.23% | -7.17% | 5.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.